Ukko

Safer Proteins for People with Food Allergies and Sensitivities

Agriculture & Food Technologies
Active
Series A Rehovot, Israel Founded 2016
Last updated 2026-06-18
Total raised
$47.7M
Last: 2025-06
Stage
Series A
Founded
2016
Headcount
51
HQ
Rehovot, Israel
Sector
Agriculture & Food Technologies

About

Ukko's mission is to improve the lives of people with food allergies and sensitivities. Ukko uses immunology, machine learning, and protein engineering to make measurably better and safer proteins for use in food and therapeutics. Ukko does this by designing and controlling the molecular interactions between allergen proteins and the immune system. Ukko's technology uses samples from patients and machine learning to guide the engineering of superior proteins that can be incorporated into food products and therapeutics. These proteins maintain or improve beneficial properties (taste, nutritional value, yield, and physicochemical and mechanical properties) but do not trigger an immune response. Ukko's initial product pipeline includes celiac-safe gluten proteins, allergy-safe and therapeutic peanut proteins, as well as a pipeline of additional allergen proteins.

Funding history · 3 rounds · $47.7M total

Q&A

What is Ukko's primary mission?
Ukko's mission is to improve the lives of people with food allergies and sensitivities by using immunology, machine learning, and protein engineering to create safer proteins for food and therapeutics.
How much funding has Ukko raised in total?
Ukko has raised a total of $47.7 million USD.
Which investors participated in Ukko's July 2017 funding round?
In July 2017, Ukko received funding from investors including Marc Benioff.
Who led Ukko's January 2021 funding round?
Ukko's January 2021 funding round was led by Leaps by Bayer, with participation from Khosla Ventures.
Where is Ukko's headquarters located?
Ukko's headquarters is located in Rehovot, Center District, Israel.
What types of proteins are in Ukko's initial product pipeline?
Ukko's initial product pipeline includes celiac-safe gluten proteins and allergy-safe and therapeutic peanut proteins.

Team · 3

Founder · Co-founder & Chairman
LinkedIn ↗
Founder · Co-founder & CEO
LinkedIn ↗
Founder · Founding Director of H. Weiser Food Allergy Center, Michigan University; CEO & CMO at FARE
LinkedIn ↗

Sectors & technology

Primary sector
Agriculture & Food Technologies
Sub-sectors
Agriculture & Food TechnologiesFood TechNovel Food & Ingredients
Technologies
Artificial IntelligenceBiologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsAgriculture & FoodProcessed FoodsIngredients
Business model
B2B

Highlights

Verified

Tags

biotechnologyfoodtechfood-ingredientsmolecular-biologyconsumersbig-datapharmaceuticalstherapeuticsimmunologyallergyproteinsartificial-intelligence
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)